ATLAS / Macro Radar / Reporting / NMRA

Neumora Therapeutics, Inc. (NMRA) reporting calendar

Neumora Therapeutics, Inc. files periodic reports with the SEC as NMRA on Nasdaq. Atlas tracks 11 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
13 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
11

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 39 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open NMRA market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-211825
10-K31 Dec 202530 Mar 202689 days0001193125-26-130388
10-Q30 Sep 20256 Nov 202537 days0001193125-25-269446
10-Q30 Jun 20256 Aug 202537 days0000950170-25-104138
10-Q31 Mar 202512 May 202542 days0000950170-25-069311
10-K31 Dec 20243 Mar 202562 days0000950170-25-030401
10-Q30 Sep 202412 Nov 202443 days0000950170-24-125437
10-Q30 Jun 20246 Aug 202437 days0000950170-24-091737
10-Q31 Mar 20247 May 202437 days0000950170-24-054448
10-K31 Dec 20237 Mar 202467 days0000950170-24-027927
10-Q30 Sep 20231 Nov 202332 days0000950170-23-057424

Source: SEC EDGAR company submissions for CIK 0001885522. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.